The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl) -N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation

Scott, G.S., Kean, R.B., Mikheeva, T., Fabis, M.J., Mabley, J.G., Szabo, C. and Hooper, D.C. (2004) The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl) -N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation Journal of Pharmacology and Experimental Therapeutics, 310. pp. 1053-1061. ISSN 1521-0103

Full text not available from this repository.
Item Type: Journal article
Subjects: B000 Health Professions > B200 Pharmacology Toxicology and Pharmacy > B210 Pharmacology and Therapeutics
DOI (a stable link to the resource): 10.1124/jpet.103.063214
Faculties: Faculty of Science and Engineering > School of Pharmacy and Biomolecular Sciences
Depositing User: editor spbs
Date Deposited: 01 Dec 2006
Last Modified: 17 Apr 2014 14:27
URI: http://eprints.brighton.ac.uk/id/eprint/809

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year